Package 0527-1931-06

{"route": ["ORAL"], "spl_id": "0a136962-d1f1-f728-e063-6394a90a01b0", "openfda": {"nui": ["N0000175935", "M0028311", "N0000182141", "N0000190114", "N0000185503"], "upc": ["0305271932068", "0305271931061"], "unii": ["H1250JIK0A"], "rxcui": ["197516", "197517"], "spl_set_id": ["9bf207c0-86eb-4f3b-92e7-f65f3fccd5a7"], "pharm_class_cs": ["Macrolides [CS]"], "pharm_class_epc": ["Macrolide Antimicrobial [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "manufacturer_name": ["Lannett Company, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0527-1931-06)", "package_ndc": "0527-1931-06", "marketing_start_date": "20191123"}], "brand_name": "Clarithromycin", "product_id": "0527-1931_0a136962-d1f1-f728-e063-6394a90a01b0", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Macrolide Antimicrobial [EPC]", "Macrolides [CS]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "0527-1931", "generic_name": "Clarithromycin", "labeler_name": "Lannett Company, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Clarithromycin", "active_ingredients": [{"name": "CLARITHROMYCIN", "strength": "250 mg/1"}], "application_number": "ANDA203584", "marketing_category": "ANDA", "marketing_start_date": "20191123", "listing_expiration_date": "20261231"}